Gilead reports updated data from trial of acclaimed HIV PrEP drug
Gilead has presented updated data for its twice-yearly pre-exposure prophylaxis (PrEP) lenacapavir, which has shown nearly perfect efficacy in two …
Post
-
-
PROCEPT BioRobotics wins FDA IDE for aquablation trial in prostate cancer
The US Food and Drug Administration (FDA) has awarded PROCEPT BioRobotics an investigational device exemption (IDE), greenlighting a pivotal trial …
-
Lebrikizumab, tralokinumab and dupilumab to compete in atopic dermatitis space
The US approval of Eli Lilly’s Ebglyss (lebrikizumab) in September 2024 places the company in a competitive position in the …
-
Intellia Therapeutics begins Phase III trial of hereditary angioedema gene therapy
US-based biotechnology company Intellia Therapeutics has begun the Phase III HAELO clinical trial of NTLA-2002, an investigational in-vivo gene editing …
-
FDA gives Adcendo green light to trial ADC in Phase I/II sarcoma study
Adcendo’s antibody-drug conjugate (ADC) candidate will enter a Phase I/II study after receiving Investigational New Drug (IND) clearance from the …
-
MHRA puts technology in the spotlight in 2024/25 business plan
The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has unveiled a new business plan to build on the launch …
-
Boehringer kickstarts two Phase III trials as MASH therapy wins breakthrough status
Boehringer Ingelheim has received a breakthrough therapy designation from the US Food and Drug Administration (FDA) for survodutide as a …
-
Johnson & Johnson discontinues Phase III study of treatment for bladder cancer
US-based pharmaceutical company Johnson & Johnson has discontinued its SunRISe-2 study for TAR-200 in muscle-invasive bladder cancer (MIBC) patients not …
-
Scholar Rock stocks skyrocket after SMA drug scores at Phase III
Scholar Rock’s stock has soared off the back of positive Phase III results from its spinal muscular atrophy (SMA) candidate. The …
-
AstraZeneca’s Phase III trial of treatment for asthma meets its primary endpoint
UK-based pharmaceutical company AstraZeneca has reported that its Phase IIIb BATURA trial of Airsupra (albuterol/budesonide) in patients with intermittent or …
-
Fish-skin grafts outperform current treatments in diabetic foot ulcers
Fish-skin grafts outperform the standard of care in closing types of diabetic foot ulcers, according to a clinical study conducted …
-
Oncolytics targets accelerated approval for oncolytic virus therapy
Oncolytics Biotech is seeking accelerated approval for its lead cancer therapy, pelareorep, with plans to start a registrational Phase II …
-
GE HealthCare’s manganese-based MRI contrast agent shines in Phase I trial
GE HealthCare has announced positive results from a Phase I study of its manganese-based macrocyclic magnetic resonance imaging (MRI) contrast …
-
University of Queensland advances spider venom-derived heart drug to trials
The University of Queensland in Australia has announced the commencement of clinical trials of Hi1a, a heart drug derived from …
-
Microbiotica initiates subject dosing in Phase Ib melanoma therapy trial
Microbiotica has dosed the first subject in the Phase Ib MELODY-1 clinical trial of MB097, a precision microbiome co-therapy targeting …
